Cargando…

Updates on enhanced recovery after surgery for radical cystectomy

Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Grace, Patel, Hiren V., Srivastava, Arnav, Ghodoussipour, Saum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280843/
https://www.ncbi.nlm.nih.gov/pubmed/35844831
http://dx.doi.org/10.1177/17562872221109022
_version_ 1784746742372106240
author Lee, Grace
Patel, Hiren V.
Srivastava, Arnav
Ghodoussipour, Saum
author_facet Lee, Grace
Patel, Hiren V.
Srivastava, Arnav
Ghodoussipour, Saum
author_sort Lee, Grace
collection PubMed
description Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting much of its supporting data from colorectal literature. In the last decade, growing interest in ERAS has increased RC-specific ERAS research, including prospective randomized controlled trials (RCTs). Collective data suggest ERAS contributes to improved complication rates, decreased hospital length-of-stay, and/or time to bowel recovery. Various institutions have adopted modified versions of the ERAS pathway, yet there remains a lack of consensus on the efficacy of specific ERAS items and standardization of the protocol. In this review, we summarize updated evidence and practice patterns of ERAS pathways for RC since the introduction of the original 2013 guidelines. Novel target interventions, including use of immunonutrition, prehabilitation, alvimopan, and methods of local analgesia are reviewed. Finally, we discuss barriers to implementing and future steps in advancing the ERAS movement.
format Online
Article
Text
id pubmed-9280843
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-92808432022-07-15 Updates on enhanced recovery after surgery for radical cystectomy Lee, Grace Patel, Hiren V. Srivastava, Arnav Ghodoussipour, Saum Ther Adv Urol Management of Bladder Cancer: What is the Evidence? Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting much of its supporting data from colorectal literature. In the last decade, growing interest in ERAS has increased RC-specific ERAS research, including prospective randomized controlled trials (RCTs). Collective data suggest ERAS contributes to improved complication rates, decreased hospital length-of-stay, and/or time to bowel recovery. Various institutions have adopted modified versions of the ERAS pathway, yet there remains a lack of consensus on the efficacy of specific ERAS items and standardization of the protocol. In this review, we summarize updated evidence and practice patterns of ERAS pathways for RC since the introduction of the original 2013 guidelines. Novel target interventions, including use of immunonutrition, prehabilitation, alvimopan, and methods of local analgesia are reviewed. Finally, we discuss barriers to implementing and future steps in advancing the ERAS movement. SAGE Publications 2022-07-12 /pmc/articles/PMC9280843/ /pubmed/35844831 http://dx.doi.org/10.1177/17562872221109022 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Management of Bladder Cancer: What is the Evidence?
Lee, Grace
Patel, Hiren V.
Srivastava, Arnav
Ghodoussipour, Saum
Updates on enhanced recovery after surgery for radical cystectomy
title Updates on enhanced recovery after surgery for radical cystectomy
title_full Updates on enhanced recovery after surgery for radical cystectomy
title_fullStr Updates on enhanced recovery after surgery for radical cystectomy
title_full_unstemmed Updates on enhanced recovery after surgery for radical cystectomy
title_short Updates on enhanced recovery after surgery for radical cystectomy
title_sort updates on enhanced recovery after surgery for radical cystectomy
topic Management of Bladder Cancer: What is the Evidence?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280843/
https://www.ncbi.nlm.nih.gov/pubmed/35844831
http://dx.doi.org/10.1177/17562872221109022
work_keys_str_mv AT leegrace updatesonenhancedrecoveryaftersurgeryforradicalcystectomy
AT patelhirenv updatesonenhancedrecoveryaftersurgeryforradicalcystectomy
AT srivastavaarnav updatesonenhancedrecoveryaftersurgeryforradicalcystectomy
AT ghodoussipoursaum updatesonenhancedrecoveryaftersurgeryforradicalcystectomy